BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 13, 2004
View Archived Issues
TT-232, a somatostatin analogue, demonstrates in vivo antitumor activity
Read More
Novel DNA intercalating agent for antitumor therapy described
Read More
Allergan plans IND filing for Peplin's topical drug for actinic keratosis
Read More
Nanogen to acquire SYN X Pharma
Read More
Lundbeck and Merck & Co. to develop and commercialize gaboxadol
Read More
Chiesi and 3M to develop Modulite HFA products for North America
Read More
MediGene completes enrollment in final phase III trial of Polyphenon E
Read More
Eisai reports on progress of global clinical development
Read More
Maxim reviews first quarter developments
Read More
Praecis achieves primary goal for 2003
Read More
Efficacy and safety of efalizumab in the treatment of psoriasis
Read More
Improved epithelial chloride transport found with Moli-1901 in cystic fibrosis
Read More
Pregabalin reported effective and safe as adjunctive therapy for patients with partial seizures
Read More
Hyperleptinemia in lean ZDF rats reduces weight and converts white adipocytes into fat burning cells
Read More
Poseidon claims new BK(Ca) channel modulators for respiratory and cardiovascular disorders
Read More
New factor Xa/factor VIIa inhibitors covered by Merck KGaA patent
Read More
Novel caspase inhibitors discovered by Vertex researchers
Read More
New NPY Y5 antagonists and their use reported by Banyu
Read More
Pharmacia team prepares and tests new MMP inhibitors
Read More
Aventis describes adenosine A1 agonists with potential as antidiabetic agents
Read More
New beta3-adrenoceptor agonists and their use in urinary incontinence
Read More
Myfortic completes European mutual recognition procedure
Read More
Riomet launched in U.S.
Read More
New phase II trial studies effects of ALT-711 on endothelial function
Read More
Improvement in cognitive function in schizophrenics after switch to ziprasidone
Read More
Aeroneb Go Nebulizer available in U.S.
Read More
Orphan drug status for Altastaph
Read More
IND filing for phase I/II AVENGE trial of EW-A-401
Read More
Fast track status for Fibrillex
Read More
Third of four phase II trials initiated for PI-88
Read More
